Effect of Xanthium Strumarium on HIV-1 5′-LTR Transcriptional Activity and Viral Reactivation in Latently Infected Cells

Chao-Jung Chen,Mu-Lin Chiu,Chien-Hui Hung,Wen-Miin Liang,Mao-Wang Ho,Ting-Hsu Lin,Xiang Liu,Hsinyi Tsang,Chiu-Chu Liao,Shao-Mei Huang,Yi-Fang Wu,Yang-Chang Wu,Te-Mao Li,Fuu-Jen Tsai,Ying-Ju Lin
DOI: https://doi.org/10.3389/fphar.2021.720821
IF: 5.6
2021-08-06
Frontiers in Pharmacology
Abstract:Chinese herbal medicines (CHMs) are widely used in Asian countries. They show multiple pharmacological activities, including antiviral activities. The 5′-long terminal repeat (LTR) region of HIV-1, required for viral transcription, is a potential drug target for HIV-1 reactivation and intrinsic cell death induction of infected or latently infected cells. Modulation of HIV-1 reactivation requires interactions between host cell proteins and viral 5′-LTR elements. By evaluation of two CHMs- Xanthium strumarium and Pueraria montana , we found that 1) X. strumarium reactivated HIV-1 latently infected cells in J-Lat 8.4, J-Lat 9.2, U1, and ACH-2 cells in vitro ; 2) 27 nuclear regulatory proteins were associated with HIV-1 5′-LTR using deoxyribonucleic acid affinity pull-down and LC-MS/MS analyses; and 3) among them, silencing of XRCC6 reactivated HIV-1 5′-LTR transcriptional activity. We found that X. strumarium inhibits the 5′-LTR associated XRCC6 nuclear regulatory proteins, increases its viral 5′-LTR promoter transcriptional activity, and reactivates HIV-1 latently infected cells in vitro . These findings may contribute to understanding the 5′-LTR activity and the host cell nuclear regulatory protein machinery for reactivating HIV-1 and for future investigations to eradicate and cure HIV-1 infection.
pharmacology & pharmacy
What problem does this paper attempt to address?